Safety and Tolerability Study of IV ST266 in COVID-19 Subjects

NCT04720378 · clinicaltrials.gov ↗

PHASE1

Phase

COMPLETED

Status

12

Enrollment

INDUSTRY

Sponsor class

Conditions

Cytokine Release Syndrome

Interventions

BIOLOGICAL: ST266

Sponsor

Noveome Biotherapeutics, formerly Stemnion

Collaborators

[object Object]